Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIPPON: 6 vs 18 months DAPT after Nobori stent
NCT01514227Phase 4Completed
- Sponsor
- Association for Establishment of Evidence in Interventions
- Start
- Dec 2011
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, clopidogrel, ticlopidine in coronary artery disease (CAD), sponsored by Association for Establishment of Evidence in Interventions. Started Dec 2011; status: completed.
02
Drugs
aspirinclopidogrelticlopidine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01514227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01514227.